RAAS Inhibitor Drugs in Dialysis Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.
Also called NCT01635387
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 350 participants
- Registry
-
NCT01635387
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT01635387. Randomized; triple masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RAAS Inhibitor Drugs in Dialysis Patients
- Condition
- Hypertension
- Condition
- End Stage Renal Disease
- Intervention (Drug)
- aliskiren
- Lead sponsor
- University of Campania Luigi Vanvitelli
- Collaborator
- IRCCS San Raffaele
Record details
- Record id
cardio:ct-nct01635387- Content hash
9ec8ace934fbc7dbd9a9c92397785dff3a616cad2e8033c6bbae1b6bc634b942